These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23545592)

  • 21. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.
    Dervieux T; Greenstein N; Kremer J
    Arthritis Rheum; 2006 Oct; 54(10):3095-103. PubMed ID: 17009228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
    Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
    Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weekly split-dose regimen for oral methotrexate reduced polyglutamation in red blood cells in patients with rheumatoid arthritis compared with single-dose regimen: Results from a multicentered randomized control trial.
    Nagaoka S; Katayama K; Kasama T; Sato M; Ohno S; Amasaki Y; Kataoka H; Furusaki A; Kon Y; Okamoto M; Sasano M; Sagawa A
    Int J Rheum Dis; 2020 Oct; 23(10):1328-1336. PubMed ID: 32896992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
    Angelis-Stoforidis P; Vajda FJ; Christophidis N
    Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis.
    Tazoe Y; Hayashi H; Tsuboi S; Shioura T; Matsuyama T; Yamada H; Hirai K; Tsuji D; Inoue K; Sugiyama T; Itoh K
    Drug Metab Pharmacokinet; 2015 Jun; 30(3):227-30. PubMed ID: 26003891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.
    Meesters RJ; den Boer E; de Jonge R; Lindemans J; Luider TM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3063-70. PubMed ID: 21953961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia.
    Choi R; Kim MJ; Ju HY; Lee JW; Lee SY
    Eur J Pharm Sci; 2024 Nov; 202():106878. PubMed ID: 39159789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Predicting the Therapeutic Response to Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Hospital-Based Cohort Study.
    Hakamata J; Kaneko Y; Shimizu M; Yamaoka K; Maruyama J; Takeuchi T; Mochizuki M; Hashiguchi M
    Biol Pharm Bull; 2018; 41(9):1414-1422. PubMed ID: 30175777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
    Stamp LK; Roberts RL
    Pharmacogenomics; 2011 Oct; 12(10):1449-63. PubMed ID: 22008049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary study to identify the predictive factors for the response to methotrexate therapy in patients with rheumatoid arthritis.
    Inoue S; Hashiguchi M; Takagi K; Kawai S; Mochizuki M
    Yakugaku Zasshi; 2009 Jul; 129(7):843-9. PubMed ID: 19571519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
    Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrocyte methotrexate-polyglutamate assay using fluorescence polarization immunoassay technique: application to the monitoring of patients with rheumatoid arthritis.
    Inoue S; Hashiguchi M; Kawai S; Mochizuki M
    Yakugaku Zasshi; 2009 Aug; 129(8):1001-5. PubMed ID: 19652507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non-target red blood cells of patients with Crohn's disease.
    van de Meeberg MM; Sundaresan J; Lin M; Jansen G; Struys EA; Fidder HH; Oldenburg B; Mares WGN; Mahmmod N; van Asseldonk DP; Rietdijk ST; Nissen LHC; de Boer NKH; Bouma G; Ćalasan MB; de Jonge R;
    Basic Clin Pharmacol Toxicol; 2024 Sep; 135(3):308-320. PubMed ID: 38973551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients.
    Leeb BF; Witzmann G; Ogris E; Studnicka-Benke A; Andel I; Schweitzer H; Smolen JS
    Clin Exp Rheumatol; 1995; 13(4):459-63. PubMed ID: 7586777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
    Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
    Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
    Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
    Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.